Paronychia Treatment Market

Paronychia Treatment Market Outlook (2023 to 2033)

The global paronychia treatment market is valued at US$ 500 million in 2023. Overall market value is estimated to touch US$ 1 billion by the end of 2033, expanding briskly at a CAGR of 7.1% from 2023 to 2033.

Paronychia, often known as whitlow, is a common skin infectious condition that affects the area around the nail. This is caused by bacteria, fungi, or both. It impacts the tissues of the nail fold and may change the texture, color, and shape of the nail. The area becomes red and inflamed, causing moderate to intense pain. It is induced by an injury to the nail region or a break in the skin between the cuticle and plate area, which is the source of the infection.

The symptoms of paronychia are easy to recognize and can typically be treated with little to no harm to skin and nails. Paronychia can develop gradually over weeks or rapidly over one or two days, based on the origin of the infection. If left untreated, the disease can progress to the point where a person can lose part or the entire nail.

Paronychia can be acute or chronic, based on the onset, duration, and infectious agents. Acute infection usually always develops swiftly around the fingernails. It is frequently the result of skin damage surrounding the nails caused by biting, hangnails, picking, manicures, or other physical trauma. In the case of acute paronychia, enterococcus and staphylococcus bacteria are common infecting agents.

Chronic paronychia can affect fingers or toes and develops gradually. It lasts for many weeks and frequently returns. It is usually caused by many infectious agents, most commonly candida bacteria and yeast. It is more common in those who are continuously in contact with water. Chronically damp skin and extensive soaking damage the cuticle's natural barrier. This causes bacteria and yeast to thrive and infiltrate the skin, resulting in an infection.

Increased need for safe and effective treatment is projected to present market participants with considerable growth prospects. The demand for safe and effective treatment is growing as the frequency of paronychia rises. Moreover, the strong emphasis on the development of novel paronychia treatments is projected to drive the global market.

• For example, TheOTCLab introduced the innovative FungeX line for nail fungus treatment in April 2020.

Fact.MR, a market research and competitive intelligence provider, expects such aspects will drive the growth of the paronychia treatment market during the forecast period.

Report Attributes	Details
Market Size in 2023	US$ 500 Million
Projected Market Value (2033)	US$ 1 Billion
Global Market Growth Rate (2023 to 2033)	7.1% CAGR
Leading Regional Market	North America
Leading Product	Mupirocin Ointment
Key Companies Profiled	Glenmark Generics Ltd GlaxoSmithKline plc Eli Lilly Company Teva Pharmaceutical Industries Ltd Fougera Pharmaceuticals Inc Jonakayem Pharma Formulation

Why is There a Pressing Need for Paronychia Treatment?

“Increasing Incidence of Diabetes Globally”

The likelihood of paronychia in diabetic patients, as well as a surge in cases of diabetes globally, are projected to spur the demand for paronychia treatment throughout the forecast period. Paronychia is more prevalent in diabetics than in non-diabetics, and diabetics are at a higher risk of significant consequences from paronychia.

• As per the International Diabetes Federation (2021 study), diabetes affected approximately 537 million persons aged 20 to 80. As per the same source, this figure is predicted to climb to 634 million by 2030 and 783 million by 2045.

“Expanding Geriatric Population Worldwide”

Skin infection treatments are in high demand due to an increasing geriatric population globally. Paronychia is more common in adults and the elderly and affects more men than women.

• As per the World Health Organization (WHO), one in every six persons worldwide is expected to be over 60 by 2030. The number of older individuals is predicted to double in Eastern and South-Eastern Asia, followed by Southern and Central Asia.

Which Factor Can Impede Market Growth to Some Extent?

“Lack of Awareness Regarding Paronychia Disease”

The primary impediment to market revenue growth is a lack of understanding about the severity of the paronychia disease. Thickening and decolorization of the nails and detachment of the nails from the nail bed are prominent symptoms of paronychia that are often overlooked.

As a consequence, the nail fungal infection goes misdiagnosed. Furthermore, many people are unaware of the infection, so they avoid therapy or medical help.

Country-wise Insights

Why is the United States Exhibiting High Demand for Paronychia Treatment?

“Rising Prevalence of Acute & Chronic Paronychia and Growing Geriatric Population”

North America is dominating the global market for paronychia treatment. Due to aspects such as the increasing rate of paronychia, growing knowledge of viable treatments, and the presence of prominent market players, the region is expected to maintain its dominance during the forecast period. Furthermore, the availability of reimbursement options for medical treatments is expected to increase regional market growth possibilities.

The United States is significantly supporting regional market growth due to the rising prevalence of acute and chronic paronychia in the country. Furthermore, well-developed technology, high healthcare expenditure, increased government support for R&D, and a changing lifestyle all contribute to the expansion of the market in the United States.

Demand for paronychia treatment is also growing due to an aging population and a rise in the number of diabetic patients in the country.

• In 2020, the Census Bureau stated that over 55 million Americans were 65 or older, with one-fourth of them residing in one of the three states of Texas, Florida, or California. Seven additional states, including Illinois, Georgia, New York, and Michigan, make up about another quarter of the population aged 65 and over.

Numerous factors, such as recurrent nail trauma, prolonged exposure to pathogenic fungus, diabetes, poor peripheral circulation, deficient immune function, inactivity, or the inability to trim toenails or maintain proper foot hygiene, contribute to the age-related rise in paronychia. Domestic enterprises are using a variety of tactics to improve their market positions, including mergers and acquisitions, research & development, and new developments.

What Roles Do Germany and the United Kingdom Play in the European Market?

“Germany and United Kingdom to Make Substantial Contribution to Regional Market Expansion”

Europe is following North America in terms of growth. The availability of funding for R&D and strong government support is fueling the regional market expansion. Countries such as Germany and the United Kingdom are boosting their investments in healthcare. Market players in these countries are continually investing in research and development to introduce superior treatment.

What is the Reason Behind South Korea's and Japan's Rising Demand for Paronychia Treatment?

“Rapidly Increasing Elderly Population”

Asia Pacific is experiencing considerable growth in the worldwide market. The regional market is expanding due to the high prevalence of paronychia. This can be ascribed to a variety of circumstances, including limited access to healthcare facilities, poor cleanliness, an aging population, and rapid urbanization. Moreover, the humid and warm climate in most parts of the region promotes the growth of paronychia. Furthermore, prominent regional market competitors are concentrating on the development of new products.

South Korea and Japan are witnessing an increase in demand for paronychia treatment due to the growing elderly population in these countries.

Category-wise Insights

Why is Mupirocin Ointment the Leading Product in the Worldwide Market?

“Low Toxicity and Favorable Outcomes of Mupirocin Ointment”

Mupirocin ointment is in great demand due to its widespread use in the treatment of acute and chronic paronychia. It is also preferred over other medications due to its minimal toxicity and excellent effects. Mupirocin is an antibiotic that works at the cellular level to treat bacterial infections by blocking cell wall formation.

The medication is available as an ointment that can be applied to affected regions twice daily for four weeks, then once daily for another four weeks, until complete healing occurs or medical counsel advises discontinuing treatment.

Patients with candida albicans-related paronychia commonly use fusidic acid ointment since it has been shown to be useful against this fungal infection while also being safer compared to other antifungal medicines.

Competitive Landscape

Key players in the paronychia treatment market are constantly focusing on developing new items to gain a global market share. As a result, these players are increasing their investment in research and development to lead the worldwide market.

Many market players are focused more on collaboration and acquisition to expand their product portfolios, allowing them to boost their presence in the worldwide market and gain the most share. Furthermore, market players are constantly attempting to close the gap between the demand and supply of quality therapy to boost profit. Start-ups operating in the global market are also concentrating on developing innovative products.

• The US Food and Drug Administration approved Bausch Health's Jublia in April 2021. Jublia is a topical solution used to treat paronychia in patients aged six and up.
• Mundipharma struck a new agreement in November 2020 with Moberg Pharma to market its consumer healthcare product for treating nail disorders throughout the Middle East & Africa (MEA). The company specializes in topical therapy for nail and skin disorders.

Key Segments of Paronychia Treatment Industry Research

• By Type :

  • Acute Paronychia
  • Chronic Paronychia

• By Product :

  • Mupirocin Ointment
  • Fusidic Acid Ointment
  • Gentamicin Ointment
  • Dicloxacillin

• By End User :

  • Hospitals & Clinics
  • Dermatology Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific & China
  • Middle East & Africa